Loading company…
Lausanne-based maker of glaucoma treatment devices, including the eyeWatch shunt.
Founded in 2010 in Lausanne, Switzerland, Rheon Medical SA develops glaucoma treatment products. Its eyeWatch shunt offers adjustable intraocular pressure management, and the eyePlate-S, which awaits EU regulatory approval, is aimed at refractory glaucoma surgery. The company sells to surgeons and clinics in Europe. It has raised CHF 5.6 million in Series C funding as of December 10, 2020, and Nikos Stergiopoulos is founder and CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in